XBiotech Inc.
XBIT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626878
No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding XBiotech Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 46 | 1 | 46 | +1 |
| Shares | 3.99M | 248.3K | 4.52M | +769.9K (+20.5%) |
| Value | $32.5M | $2.02M | $23.2M | −$7.23M (−23.7%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held XBiotech Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Asset Management Americas Inc | 248,270 | $1.28M | 0.00% |
| American Century Companies Inc | 76,460 | $393.0K | 0.00% |
| Nuveen Asset Management, LLC | 24,879 | $127.9K | 0.00% |
| New York State Common Retirement Fund | 21,700 | $111.5K | 0.00% |
| Alpine Global Management, LLC | 17,809 | $91.5K | 0.02% |
| Man Group plc | 10,611 | $54.5K | 0.00% |
| Corebridge Financial, Inc. | 9,955 | $51.3K | 0.00% |
| Barclays PLC | 7,582 | $39.0K | 0.00% |
| Ameritas Investment Partners, Inc. | 1,813 | $9.32K | 0.00% |
| Legal & General Group Plc | 1,598 | $8.14K | 0.00% |
| California State Teachers Retirement System | 1,341 | $6.89K | 0.00% |
| Amalgamated Bank | 640 | $3.00K | 0.00% |
| US Bancorp | 100 | $514 | 0.00% |
Sold out (12)
Institutions that held XBiotech Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Susquehanna International Group, LLP | 169,812 | $1.38M |
| Jane Street Group, LLC | 54,822 | $445.7K |
| HRT Financial LP | 33,593 | $273.0K |
| Point72 Asia (Singapore) Pte. Ltd. | 25,954 | $211.0K |
| Balyasny Asset Management LLC | 21,865 | $177.8K |
| Brevan Howard Capital Management LP | 20,578 | $167.3K |
| Two Sigma Advisers, LP | 18,433 | $149.9K |
| Y-Intercept (Hong Kong) Ltd | 18,043 | $146.7K |
| ExodusPoint Capital Management, LP | 16,177 | $132.0K |
| Two Sigma Investments, LP | 10,707 | $87.0K |
| Cubist Systematic Strategies, LLC | 5,254 | $42.7K |
| Macquarie Group Ltd | 576 | $5 |
Not filed for Q2 2024 yet (1)
Institutions that held XBiotech Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 248,270 | $2.02M |